PAR · —

bioMérieux S.A. (BIM.PA) Stock

$88.25 +1.15% PAR: BIM.PA —

—

Valuation

MetricValue
Price$88.25
Market Cap$10.27B
P/E Ratio22.37
P/B Ratio2.39
P/S Ratio2.57
EPS (TTM)$3.90
52-Week High$116.10
52-Week Low$65.60
Dividend Yield1.14%

Financials & Margins

MetricValue
ROE11.22%
ROA7.23%
ROCE—
Gross Margin56.13%
Operating Margin15.23%
Net Margin11.59%
Debt/Equity0.10
Current Ratio2.30

Valuation & Return Ratios

MetricValue
PEG Ratio1.98
EV / EBITDA9.59
FCF Yield—
Quick Ratio1.44
Interest Coverage—
Return 1Y-20.59%
Return 3Y2.77%
Return 5Y-13.31%

Ownership

Insiders Held66.46%
Institutions Held16.36%
Institutions Float Held48.77%
Institutional HolderSharesReport Date
Pacer Advisors, Inc.2022026-06-30

About bioMérieux S.A.

—

bioMérieux S.A. (BIM.PA) stock trades at $88.25 with a market capitalization of $10.27B. The stock is valued at a price-to-earnings (P/E) ratio of 22.37, price-to-book of 2.39, price-to-sales of 2.57. Over the past 52 weeks the stock has ranged between $65.60 and $116.10, and currently trades 24.0% below its 52-week high. It pays a dividend yielding 1.14%.

On profitability, bioMérieux S.A. generates a return on equity (ROE) of 11.22%, an operating margin of 15.23%, a net profit margin of 11.59%.

Official website: www.biomerieux.com

bioMérieux S.A. (BIM.PA) — frequently asked questions

What is bioMérieux S.A. (BIM.PA) stock price today?

bioMérieux S.A. (BIM.PA) is currently trading at $88.25, up 1.15% today.

What is BIM.PA P/E ratio?

bioMérieux S.A.'s P/E ratio is 22.37. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is BIM.PA return on equity (ROE)?

bioMérieux S.A.'s return on equity (ROE) is 11.22%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is bioMérieux S.A.'s market cap?

bioMérieux S.A. has a market capitalization of $10.27B.

Does BIM.PA pay a dividend?

Yes. bioMérieux S.A. currently yields 1.14%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does BIM.PA carry?

bioMérieux S.A. has a debt-to-equity ratio of 0.10. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is BIM.PA's profit margin?

bioMérieux S.A. reports a net profit margin of 11.59% — the share of revenue left after every cost, including tax and interest.

What sector is BIM.PA in?

bioMérieux S.A. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is BIM.PA listed on?

bioMérieux S.A. trades on PAR under the ticker BIM.PA.

What is BIM.PA's 52-week range?

Over the last year bioMérieux S.A. has traded between $65.60 and $116.10.

Related — Stocks

INIO INNIO N.V. $15.21 +0.66% USDE StablecoinX Inc. $1.00 -0.01% SGP SpyGlass Pharma, Inc. $28.48 +0.92% APMD Apnimed, Inc. $18.99 +2.48% GLAS Glass House Brands Inc. Subordinate Voting Shares $2.14 -6.14% GIXI Gix Internet Ltd. $4.23 +4.44%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens BIM.PA currently matches

On the figures above, bioMérieux S.A. passes the filters for 11 of our ready-made screens, among them Dividend Stocks, Low Debt Stocks, Large Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Dividend StocksLow Debt StocksLarge Cap StocksStocks Under $100High Gross Margin StocksLarge Cap Dividend StocksStocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 StocksHigh Current Ratio StocksLow Debt Large Cap Stocks

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.